Literature DB >> 33867229

National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States.

Peng-Jun Lu1, David Yankey2, Benjamin Fredua2, Mei-Chuan Hung2, Tanja Y Walker2, Lauri E Markowitz3, Laurie D Elam-Evans2.   

Abstract

PURPOSE: Human papillomavirus (HPV) vaccination in the United States has been recommended for girls since 2006 and for boys since 2011. However, settings of receiving HPV vaccination have not been assessed. The purpose of this study is to assess settings of receiving HPV vaccination among adolescents in order to understand what strategies are needed to improve vaccination uptake.
METHODS: Data from the 2018 National Immunization Survey-Teen (NIS-Teen) were analyzed to assess place of HPV vaccination overall, and by gender, quarter, and other selected variables among adolescents in the United States. The 2016-2018 NIS-Teen data were combined to assess state-specific place of HPV vaccination.
RESULTS: Among vaccinated adolescents aged 13-17 years, a doctor's office was the most common place where HPV vaccination was received (79.2%), followed by clinics, health centers, or other medical facilities (13.5%), health department (4.1%), hospital or emergency room (2.3%), schools (.5%), and pharmacies or stores (.4%). Overall, 99.1% of adolescents aged 13-17 years received HPV vaccination at medical settings and only .9% at nonmedical settings. Reported vaccination in nonmedical settings by state ranged from less than .1% in Delaware, Florida, and New Hampshire to 4.1% in North Dakota, with a median of 1.0%.
CONCLUSIONS: Doctor's offices were the most common medical setting for adolescents to receive HPV vaccination. Less than 1% of adolescents received vaccination at nonmedical settings. Continuing work with medical and nonmedical settings to identify and implement appropriate strategies are needed to improve HPV vaccination coverage among adolescents. Published by Elsevier Inc.

Entities:  

Keywords:  Adolescents; Coverage; Human papillomavirus (HPV) vaccine; Medical settings; National Immunization Survey-Teen (NIS-Teen); Nonmedical settings; Place of vaccination; Vaccination

Mesh:

Substances:

Year:  2021        PMID: 33867229      PMCID: PMC9080285          DOI: 10.1016/j.jadohealth.2021.03.005

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   7.830


  30 in total

1.  The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation.

Authors:  R R Deuson; E J Hoekstra; R Sedjo; G Bakker; P Melinkovich; D Daeke; A L Hammer; D Goldsman; F N Judson
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

2.  Safety of influenza vaccinations administered in nontraditional settings.

Authors:  Sarah J D'Heilly; Mary Ann Blade; Kristin L Nichol
Journal:  Vaccine       Date:  2006-02-09       Impact factor: 3.641

3.  Adolescent vaccination: recommendations from the National Vaccine Advisory Committee.

Authors:  Shannon Stokley; Gary Freed; Robin Curtis; Lance Gordon; Sharon Humiston; Trish Parnell; Andrew Pavia; Adele Young; David Johnson; Allison Kennedy; Dan Hopfensperger; Lauri Markowitz; Jaime Fergie; Mary Beth Koslap-Petraco; Mary McCauley
Journal:  Am J Prev Med       Date:  2009-01-21       Impact factor: 5.043

4.  Immunization in the United States: Recommendations, Barriers, and Measures to Improve Compliance: Part 1: Childhood Vaccinations.

Authors:  C Lee Ventola
Journal:  P T       Date:  2016-07

Review 5.  A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States.

Authors:  Katharine J Head; Erika Biederman; Lynne A Sturm; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

6.  Place of influenza vaccination among adults --- United States, 2010-11 influenza season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-06-17       Impact factor: 17.586

7.  Patients' acceptance of traditional and nontraditional immunization providers.

Authors:  M E Ernst; G R Bergus; B A Sorofman
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Jan-Feb

8.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

9.  School Entry Requirements and Coverage of Nontargeted Adolescent Vaccines.

Authors:  Jennifer L Moss; Paul L Reiter; Young K Truong; Barbara K Rimer; Noel T Brewer
Journal:  Pediatrics       Date:  2016-11-08       Impact factor: 7.124

10.  National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.

Authors:  Laurie D Elam-Evans; David Yankey; Jenny Jeyarajah; James A Singleton; Robinette C Curtis; Jessica MacNeil; Susan Hariri
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-25       Impact factor: 17.586

View more
  2 in total

1.  Trends in adolescent COVID-19 vaccination receipt and parental intent to vaccinate their adolescent children, United States, July to October, 2021.

Authors:  Kimberly H Nguyen; Kimchi Nguyen; Megan Geddes; Jennifer D Allen; Laura Corlin
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

2.  HPV vaccination and factors influencing vaccine uptake among people of Indian ancestry living in the United States.

Authors:  Philip Ratnasamy; Anees B Chagpar
Journal:  Epidemiol Infect       Date:  2022-07-27       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.